Nutritional Therapy in Elderly with Heart Failure

老年心力衰竭的营养治疗

基本信息

  • 批准号:
    9332297
  • 负责人:
  • 金额:
    $ 54.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-15 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

7. Project Summary/Abstract We have developed a nutritional formulation of amino acids called UpBeat that is designed to promote physical function and quality of life in older individuals with heart failure. Reduced exercise capacity is a prominent clinical feature of heart failure. This leads to progressive muscle weakness and a vicious cycle of sedentary behavior, weight gain, and subsequent development of metabolic abnormalities and sarcopenia. The impairment of physical function limits the health-related quality of life. Because of the limited capacity for exercise in most individuals with heart failure and the failure of drug therapy to completely resolve the symptoms, a wide variety of nutritional products have been marketed for therapy for heart failure. The data supporting the value of nutritional supplements for heart failure currently on the market either do not exist or are equivocal. UpBeat differs from most nutritional products for heart failure because it targets skeletal muscle function, and its value is supported by strong preliminary data. It is the goal of the current proposal to perform a randomized clinical trial (RCT) to test the ability of UpBeat to improve physical function and quality of life in older individuals with heart failure. The Specific Aims of this Phase II project are as follows: Specific Aim #1: We propose that 16 weeks of regular consumption of UpBeat will improve physical function in individuals with heart failure. Specific Aim #2: We propose that regular consumption of UpBeat will improve health-related quality of life. Specific Aim #3: We propose that regular consumption of UpBeat will lower the fasting concentrations of blood glucose and insulin, as well as triglycerides and low-density lipids. Positive results of this randomized clinical trial will provide evidence of the benefits of UpBeat for therapy of heart failure. In a more general sense, positive results will substantiate the benefits of targeting skeletal muscle function as a means to improve physical function and quality of life in heart failure.
7.项目总结/摘要 我们开发了一种名为UpBeat的氨基酸营养配方,旨在促进 老年心力衰竭患者的身体功能和生活质量。运动能力下降是一种 心力衰竭的突出临床特征。这会导致进行性肌肉无力和恶性循环, 久坐行为、体重增加以及随后的代谢异常和肌肉减少症的发展。的 身体功能受损限制了与健康有关的生活质量。由于能力有限, 运动在大多数患有心力衰竭和药物治疗失败的个体中完全解决了 由于心力衰竭的症状,各种各样的营养产品已经上市用于治疗心力衰竭。数据 支持目前市场上的心力衰竭营养补充剂的价值的证据要么不存在, 模棱两可。UpBeat与大多数心力衰竭营养产品不同,因为它针对骨骼肌 功能,其价值得到了强有力的初步数据的支持。本提案的目标是执行一项 随机临床试验(RCT),以测试UpBeat改善身体功能和生活质量的能力, 老年心力衰竭患者 第二阶段项目的具体目标如下: 具体目标#1:我们建议,16周的定期消费UpBeat将改善身体状况 在心力衰竭患者中的作用。 具体目标#2:我们建议定期食用UpBeat将改善与健康相关的质量, 生活 具体目标#3:我们建议定期食用UpBeat将降低空腹浓度 血糖和胰岛素,以及甘油三酯和低密度脂蛋白。 这项随机临床试验的积极结果将为UpBeat的益处提供证据, 心力衰竭的治疗从更广泛的意义上说,积极的结果将证实目标确定的好处 骨骼肌功能是改善心力衰竭患者身体功能和生活质量的一种手段。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT R WOLFE其他文献

ROBERT R WOLFE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT R WOLFE', 18)}}的其他基金

Amino Acids and Pediatric Hepatic Steatosis
氨基酸和小儿脂肪肝
  • 批准号:
    10747273
  • 财政年份:
    2023
  • 资助金额:
    $ 54.47万
  • 项目类别:
Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery
减肥手术后肌肉蛋白质合成和代谢率的营养刺激
  • 批准号:
    10005845
  • 财政年份:
    2020
  • 资助金额:
    $ 54.47万
  • 项目类别:
Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery
减肥手术后肌肉蛋白质合成和代谢率的营养刺激
  • 批准号:
    10482325
  • 财政年份:
    2020
  • 资助金额:
    $ 54.47万
  • 项目类别:
Muscle preservation during weight loss in older, overweight individuals
老年超重人士减肥期间的肌肉保存
  • 批准号:
    8979655
  • 财政年份:
    2015
  • 资助金额:
    $ 54.47万
  • 项目类别:
Nutritional Therapy in Elderly with Heart Failure
老年心力衰竭的营养治疗
  • 批准号:
    8905904
  • 财政年份:
    2015
  • 资助金额:
    $ 54.47万
  • 项目类别:
Substrate Cycling in Energy Metabolism
能量代谢中的底物循环
  • 批准号:
    8068084
  • 财政年份:
    2010
  • 资助金额:
    $ 54.47万
  • 项目类别:
Stable Isotope Analytical Core for Studies in Human Metabolism
用于人类代谢研究的稳定同位素分析核心
  • 批准号:
    7848618
  • 财政年份:
    2009
  • 资助金额:
    $ 54.47万
  • 项目类别:
Stable Isotope Analytical Core for Studies in Human Metabolism
用于人类代谢研究的稳定同位素分析核心
  • 批准号:
    7943931
  • 财政年份:
    2009
  • 资助金额:
    $ 54.47万
  • 项目类别:
RESTING ENERGY EXPENDITURE AND AMINO ACID SUPPLEMENTAITON IN YOUNG HEALTHY AD
年轻健康广告中的静息能量消耗和氨基酸补充
  • 批准号:
    7605415
  • 财政年份:
    2007
  • 资助金额:
    $ 54.47万
  • 项目类别:
EFFECTS OF LEUCINE ENHANCED AMINO ACID DRINK ON MUSCLE PROTEIN METABOLISM IN THE
亮氨酸增强氨基酸饮料对肌肉蛋白质代谢的影响
  • 批准号:
    7605384
  • 财政年份:
    2007
  • 资助金额:
    $ 54.47万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 54.47万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 54.47万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了